Arkolith/Insider Trading/RAPP/Form 4

Yeleswaram Krishnaswamy

Chief Development OfficerRapport Therapeutics, Inc. (RAPP) · full profile →Form 4 · filed Apr 21, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$809K
Net Open-Market Flow
-$809K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 17, 2026Sell(S)20K$39.99$809K246K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-167091) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML